e-Pakiet dla mężczyzn — Men's Health Panel

Men-focused 17-marker panel covering haematology, PSA for prostate screening, lipid profile, liver enzymes, kidney function, uric acid, HbA1c, thyroid, inflammation, and vitamin D3. At 399 PLN (~92 EUR) with blood draw included. Addresses the leading modifiable health risks in men — cardiovascular disease, metabolic syndrome, and prostate malignancy.

This panel is built around the three clinical domains that dominate male morbidity and mortality: cardiovascular disease, metabolic syndrome, and prostate cancer. Prostate-specific antigen (PSA) screens for the most commonly diagnosed non-skin malignancy in European men. A total PSA above 4.0 ng/mL traditionally triggers urological evaluation, though age-adjusted thresholds improve specificity — a value of 2.5 ng/mL may warrant investigation in men under 50. The European Association of Urology advises baseline measurement between ages 40 and 45, with subsequent intervals based on the initial result. Cardiovascular disease causes more deaths in European men than any other condition. The full lipidogram, combined with blood pressure and smoking history, enables SCORE2 risk calculation — the European standard for 10-year event prediction. HbA1c adds a 2-3 month glycaemic window, screening for diabetes and pre-diabetes. Type 2 diabetes prevalence is substantially higher in men at younger ages, and the condition frequently remains undiagnosed until complications emerge. The liver panel (AST, ALT) is particularly relevant given higher rates of alcohol-related liver disease and non-alcoholic fatty liver in men. Creatinine with eGFR assesses renal function. Uric acid screens for hyperuricaemia — gout affects men 3-4 times more often than women and correlates independently with cardiovascular mortality. TSH provides thyroid screening. Although thyroid dysfunction is less prevalent in men, it remains underdiagnosed because symptoms overlap with common male complaints — fatigue, low mood, weight gain, reduced libido. Vitamin D3 addresses the endemic deficiency at Central European latitudes. The complete blood count screens for anaemia, infection, and blood disorders. CRP and ESR provide systemic inflammation assessment. At 399 PLN in Diagnostyka's headquarters city, this panel offers comprehensive male health coverage that would cost 400-700 EUR at a German private laboratory. Krakow's accessibility via budget flights from across Europe makes combining a city break with health screening economically sensible.